Health ❯ Healthcare ❯ Weight Management

Obesity

Weight Loss Medications Semaglutide GLP-1 for Weight Loss GLP-1 Medications Weight-Loss Drugs BMI Weight-loss Medications Patient Support Overweight Weight Stigma

Study Links GLP‑1 Diabetes Drugs to Small Rise in Smell and Taste Diagnoses

Researchers point to GLP‑1 receptors in taste and olfactory tissue and call for targeted studies to determine whether the association is causal

Roche Stops Phase 3 for Acmopatide After Positive Phase 2 in Type 1 Diabetes

GLP-1 Drugs Linked to Lower Migraine Drug Use in Women, Fewer Asthma Flares in Danish Data

Tirzepatide Linked to Lower Death and Heart Events After PCI and TAVR in New Real-World Analyses

Heart Risks Rebound After GLP-1 Breaks, New Data Show Continuous Use Is Safest

UK Regulator Adds Rare Vision‑Loss Warning to Ozempic, Wegovy and Rybelsus

UK Regulator Flags Rare Pancreatitis, Including Deaths, Tied to Wegovy and Mounjaro

Ariel Ansaldo Quits 'Cuestión de Peso' Live, Says 'Nothing Is What It Seems' at the Clinic

FDA Clears Signos’ AI CGM for Weight Management as OTC Service Launches

UK and Eli Lilly Unveil £85m Pilot for Pharmacy and Digital Delivery of Weight-Loss Injections

NICE Requires Yearlong Follow-Up for NHS Weight-Loss Injection Patients

Weight-Loss Injections Show Sharp Rebound Eight Weeks After Ending Therapy

Semaglutide Demonstrates Dual Promise in Type 1 Diabetes and Dementia Prevention

Katie Price Sends Son Harvey Back to College After He Smashes £3,000 TV

Diabetes Drug Metformin Reduces Knee Pain in Osteoarthritis Patients, Study Finds

Warnings Issued Over Unsafe Online Sales of Weight-Loss Injections

New Studies Confirm Safety of Semaglutide for Mental Health